X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (565) 565
Newsletter (43) 43
Book Review (23) 23
Publication (21) 21
Dissertation (3) 3
Book Chapter (1) 1
Conference Proceeding (1) 1
Magazine Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ximelagatran (518) 518
humans (413) 413
warfarin (249) 249
venous thromboembolism (188) 188
anticoagulants - therapeutic use (187) 187
prevention (163) 163
atrial fibrillation (149) 149
index medicus (140) 140
anticoagulants (138) 138
male (133) 133
benzylamines (131) 131
direct thrombin inhibitor (129) 129
melagatran (127) 127
peripheral vascular disease (125) 125
hematology (124) 124
administration, oral (115) 115
thrombin - antagonists & inhibitors (114) 114
pharmacology & pharmacy (111) 111
stroke prevention (111) 111
anticoagulants - administration & dosage (108) 108
azetidines - therapeutic use (108) 108
anticoagulants - adverse effects (105) 105
female (104) 104
stroke - prevention & control (101) 101
atrial fibrillation - drug therapy (97) 97
thromboembolism (95) 95
aged (93) 93
stroke (92) 92
thrombin (90) 90
deep-vein thrombosis (85) 85
knee replacement (82) 82
atrial fibrillation - complications (80) 80
risk factors (80) 80
warfarin - therapeutic use (79) 79
cardiac & cardiovascular systems (78) 78
nonvalvular atrial-fibrillation (78) 78
total hip (77) 77
middle aged (76) 76
dabigatran (74) 74
adult (72) 72
treatment outcome (72) 72
anticoagulation (71) 71
thromboembolism - prevention & control (71) 71
anticoagulants - pharmacology (70) 70
azetidines - administration & dosage (70) 70
medicine, general & internal (65) 65
randomized controlled-trial (65) 65
animals (64) 64
molecular-weight heparin (63) 63
enoxaparin (61) 61
azetidines - pharmacology (60) 60
drug therapy (59) 59
venous thrombosis - prevention & control (59) 59
aspirin (58) 58
heparin (58) 58
pharmacokinetics (57) 57
stroke - etiology (55) 55
dose-response relationship, drug (53) 53
oral ximelagatran (53) 53
azetidines - pharmacokinetics (51) 51
azetidines - adverse effects (49) 49
clinical trials as topic (49) 49
hemorrhage - chemically induced (49) 49
randomized controlled trials as topic (49) 49
antithrombotic therapy (46) 46
glycine - analogs & derivatives (46) 46
thrombosis (45) 45
anticoagulants - pharmacokinetics (43) 43
trial (43) 43
benzylamines - therapeutic use (42) 42
double-blind method (42) 42
medicine & public health (42) 42
pharmacodynamics (42) 42
prophylaxis (42) 42
risk (42) 42
aged, 80 and over (41) 41
venous thrombosis - drug therapy (41) 41
dabigatran etexilate (40) 40
total knee replacement (40) 40
fibrinolytic agents - therapeutic use (39) 39
blood coagulation - drug effects (38) 38
double-blind (38) 38
direct thrombin inhibitors (37) 37
therapy (37) 37
medical and health sciences (36) 36
medicin och hälsovetenskap (36) 36
thrombin inhibitor ximelagatran (35) 35
management (34) 34
surgery (34) 34
dosage and administration (33) 33
factor xa inhibitors (33) 33
research (33) 33
pharmacology/toxicology (32) 32
randomized-trial (32) 32
warfarin - administration & dosage (32) 32
warfarin - adverse effects (32) 32
risk assessment (31) 31
total hip-replacement (31) 31
clinical trials (30) 30
internal medicine (30) 30
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (559) 559
German (25) 25
French (17) 17
Turkish (5) 5
Spanish (4) 4
Italian (2) 2
Dutch (1) 1
Japanese (1) 1
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 02/2005, Volume 293, Issue 6, pp. 681 - 689
CONTEXT Ximelagatran, an oral direct thrombin inhibitor with a rapid onset of action and predictable antithrombotic effect, has the potential to be a simple... 
ORAL XIMELAGATRAN | ENOXAPARIN | MEDICINE, GENERAL & INTERNAL | KNEE REPLACEMENT | THERAPY | VENOUS THROMBOEMBOLISM | MELAGATRAN | INTRAVENOUS UNFRACTIONATED HEPARIN | ABSORPTION | INHIBITOR XIMELAGATRAN | SECONDARY PREVENTION | Prodrugs - administration & dosage | Recurrence | Anticoagulants - administration & dosage | Humans | Middle Aged | Male | Venous Thrombosis - complications | Heparin, Low-Molecular-Weight - therapeutic use | Warfarin - administration & dosage | Warfarin - therapeutic use | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Pulmonary Embolism - complications | Double-Blind Method | Venous Thrombosis - drug therapy | Venous Thrombosis - mortality | Anticoagulants - therapeutic use | Treatment Outcome | Azetidines - administration & dosage | Azetidines - therapeutic use | Benzylamines | Aged | Prodrugs - therapeutic use | Alanine Transaminase - metabolism | Heparin, Low-Molecular-Weight - administration & dosage | Clinical trials | Cardiac arrhythmia | Thrombolytic drugs | Medical treatment | Blood clots | Low-Molecular-Weight/administration & dosage/therapeutic use | Anticoagulants/administration & dosage/therapeutic use | Pulmonary Embolism/complications | Drug Therapy | MEDICIN OCH HÄLSOVETENSKAP | Alanine Transaminase/metabolism | Warfarin/administration & dosage/therapeutic use | 80 and over | Azetidines/administration & dosage/therapeutic use | Combination | Prodrugs/administration & dosage/therapeutic use | Venous Thrombosis/complications/drug therapy/mortality | Heparin | MEDICAL AND HEALTH SCIENCES
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 03/2014, Volume 12, Issue 3, pp. 320 - 328
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2009, Volume 361, Issue 24, pp. 2342 - 2352
Journal Article
Circulation, ISSN 0009-7322, 02/2012, Volume 125, Issue 5, pp. 669 - 676
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 01/2011, Volume 57, Issue 2, pp. 173 - 180
Journal Article
Journal Article
European heart journal, ISSN 0195-668X, 2011, Volume 32, Issue 22, pp. 2781 - 2789
Journal Article